There were so many productive side meetings for investors and founders taking place, which is always a good sign. I met with a couple of my portfolio company CEOs during the day, as well as a few VCs that we often invest with.

This has quickly become a top meeting for investors active in the life science and clinical trial space. And the icing on the cake at this event is the opportunity to catch-up with the many industry leading CEOs, incumbents, regulators and startups attending the other tracks at the broader SCOPE conference.

Board Member, Angelini Ventures

Clinical Trial Tech is the go-to conference for clinical operations investing!

Vice President & Partner, McKesson Ventures

It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!

PhD, Managing Director, Boehringer Ingelheim Venture Fund

Nothing compares to bringing together startups, investors and ultimate acquirers/customers in a specific market. The SCOPE Investor track delivered this in spades for the clinical trial market.

Founder & Managing Partner, SPRIG Equity

It was truly a pleasure participating in this excellent SCOPE Investor and Innovation Conference. It was my first SCOPE experience and I will be back!

Global Head, Healthcare + Life Sciences, Amazon Web Services LLC

The SCOPE 2023 conference marked an exciting inflection point for the clinical trial industry as the future of clinical trials is unfolding. With the caliber of tracks, sessions, speakers, panels resulting in timely and provocative topics, SCOPE has become an important meeting that can't be missed. I left the conference thinking about how much we as an industry have evolved, how much more there is to do and how SCOPE is a great meeting place for advancing the industry.

Founder, Hawthorne Effect, Inc.

Software innovation in the clinical domain, and pharma more broadly, is one of our top priorities – SCOPE is a fantastic venue to get together with thought leaders, innovators, and of course our portfolio companies sharing our passion for the space.

Vice President, Insight Partners